CLINICAL_TRIALS
trial_result
· 2012-09-12
Clinical Trial Update: Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy [Phase 3]
Summary
A Phase 3 study evaluating adjunctive zonisamide for myoclonic seizures in idiopathic generalized epilepsy was terminated; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Limited | Conditions: Epilepsy | Phase 3 | Status: TERMINATED | Results posted: 2012-09-12